Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
Public ClinicalTrials.gov record NCT00415571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to assess and compare the preliminary efficacy, safety and tolerability of fispemifene 300 mg and placebo given once daily for 8 weeks in the treatment of hypogonadal men with erectile dysfunction (ED) unresponsive to PDE5 inhibitors.
Study identification
- NCT ID
- NCT00415571
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2006
- Primary completion
- Not listed
- Completion
- Jul 31, 2008
- Last update posted
- Feb 2, 2010
2006 – 2008
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research | Birmingham | Alabama | 35209 | — |
| Genova Clinical Research | Tucson | Arizona | 85741 | — |
| HealthStar Research | Hot Springs | Arkansas | 71913 | — |
| Genesis Research International | Longwood | Florida | 32779 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Radiant Research | West Palm Beach | Florida | 33407 | — |
| Regional Urology | Shreveport | Louisiana | 71106 | — |
| Office of Stephen Miller | Las Vegas | Nevada | 89144 | — |
| Hamilton Urology | Hamilton | New Jersey | 08690 | — |
| Center for Urologic Research of WNY, LLC | Williamsville | New York | 14221 | — |
| Metrolina Urology Clinic | Charlotte | North Carolina | 28207 | — |
| NorthEast Urology research | Concord | North Carolina | 28025 | — |
| Urology Associates, P.C. | Nashville | Tennessee | 37209 | — |
| Radiant Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00415571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2010 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00415571 live on ClinicalTrials.gov.